Just - Evotec Biologics
Michael Sennett is a skilled scientist with extensive experience in biochemistry and biophysics. Currently serving as a Senior Scientist at Just - Evotec Biologics since June 2023, Michael leads teams in developing ML-generated therapeutic libraries and optimizing protein designs. Previously, as a Postdoctoral Researcher at Brandeis University, Michael developed software simulating protein evolution and created a computational workflow for predicting protein sequences. Michael has also worked at Regeneron Pharmaceuticals, focusing on biophysical characterization of monoclonal antibodies, and has held research positions at Penn State University and University at Buffalo, acquiring a strong foundation in protein analysis and nano-scale characterizations. Michael holds a Ph.D. in Biochemistry and Biophysics from Brandeis University and has advanced degrees from Penn State University and Canisius University.
This person is not in the org chart
Just - Evotec Biologics
1 followers
Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com